Antibody Mediated Prevention (AMP) trials data published by the
New England Journal of Medicine
Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains
Public Relations Pacific LLC
E-Mail
SEATTLE - (EMBARGOED UNTIL MARCH 17, 2021, AT 5 P.M. ET) - The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This finding was seen both in Sub-Saharan Africa and the U.S. and South America. VRCO1 did not prevent the acquisition of HIV to strains that were resistant to the bNAb. As the resistant strains constituted nearly 70% of the circulating strains in these regions, there was no difference noted between the VRC01 arms and placebo arm in terms of overall prevention of HIV acquisition. The sensitivity to bNAbs was assessed by a laborat
Several effective COVID-19 vaccines have been developed in rapid time, but that may have been the easy part. Are intellectual property protections and for-profit pharmaceutical companies now getting in the way of vaccinating the world s population?
On the 12th of April 1955, the results of the largest clinical experiment in history were revealed. Called the Francis Field Trial, nearly two million children played a role in testing a novel polio vaccine that was found to be incredibly effective in preventing infection.
That same day, an interview aired with Jonas Salk, lead researcher on the vaccine project. In the interview Salk was asked who owned the patent for the polio vaccine and he famously replied, “… the people I would say. There is no patent. Could you patent the sun?”
How arts organizations can reopen their venues in 2021 is the topic of a webinar presented by the National Endowment for the Arts with special guest Dr. Anthony S. Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health.
AstraZeneca to supply US government with 500,000 additional doses of its COVID-19 antibody pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.